Wollenberg A, Cork M, Flohr C, Bewley A, Blauvelt A, Hong C- ho, Imafuku S, Schuttelaar ML, Simpson E, Soong W, Amoudruz P, Wendicke Lophaven K, Kurbasic A, Soldbro L, Strange Vest N, Paller A. Safety of tralokinumab in pediatric patients aged 12-17 years with moderate to severe atopic dermatitis: results from the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s140. Available from: https://jofskin.org/33014/index.php/skin/article/view/2029